Article(id=1327672348007837701, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.09.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1652112000000, receivedDateStr=2022-05-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471354724, onlineDateStr=2026-11-12, pubDate=1662739200000, pubDateStr=2022-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471354724, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471354724, creator=13701087609, updateTime=1794471354724, updator=13701087609, issue=Issue{id=1327672325740278619, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='9', pageStart='1227', pageEnd='1376', issueExtLink='null', onlineDate='null', pubDate='1662739200000', pubDateStr='2022-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471349414, creator='13701087609', updateTime=1794472133529, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675615098024900, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675615098024901, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672325740278619, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1240, endPage=1250, ext={EN=ArticleExt(id=1327672348179804166, articleId=1327672348007837701, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Lipid Nanocarriers for Oral Delivery of Protein and Peptide Drugs, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Protein and peptide drugs(PPDs) have good specificity, biocompatibility and good therapeutic effects. Due to the better patient compliance and safety of oral administration route, the oral delivery of PPDs has become one of the current research hotspots in the field of materials science and pharmaceuticals. However, the stability and absorption of oral biomacromolecules in the gastrointestinal tract are restricted. Lipid nanocarriers can effectively encapsulate lipophilic or hydrophilic PPDs through chemical modification, hydrophobic ion pairing and other methods. At the same time, the surface modification of lipid nanocarriers can overcome many physiological barriers of the oral absorption, which in turn promote the dissolution of PPDs in mixed micelles and strengthen lymphatic uptake. Therefore, it has good biocompatibility and high in vivo stability. In this paper, the encapsulation methods of lipid nanocarriers for PPDs and the corresponding mechanisms of overcoming physiological barriers are reviewed, and the important properties and latest research progress of lipid nanocarriers to improve the oral bioavailability of PPDs are introduced, the potential application and development prospects are further prospected as well.
, authors=Junfang OUYANG, Yongjie ZHANG, Xijing CHEN
*, authorsList=Junfang OUYANG, Yongjie ZHANG, Xijing CHEN, authorCompany=null, correspAuthors=Xijing CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327672348389519367, articleId=1327672348007837701, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=脂质纳米载体用于口服递送蛋白多肽药物的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=
蛋白多肽药物具有良好的特异性和生物相容性,治疗效果较好。由于口服给药途径的患者顺应性和安全性更佳,蛋白多肽药物的口服递送已成为当前材料学与药剂学领域的研究热点之一。然而,口服生物大分子药物在胃肠道的稳定性及吸收程度却非常受限。脂质纳米载体能通过化学修饰、疏水离子配对等多种方式有效包载亲脂或亲水性蛋白多肽药物,同时经表面修饰后的脂质纳米载体能克服口服吸收的众多生理屏障,继而促进药物在混合胶束中溶解,增强淋巴摄取,因此具有良好生物相容性和体内稳定性。本研究综述了脂质纳米载体对蛋白多肽药物的包载方式及其克服生理屏障的相应机制,介绍了其提高蛋白多肽药物口服生物利用度的重要特性和最新研究进展,并展望了其潜在应用及发展前景。
, authors=欧阳俊芳, 张永杰, 陈西敬
*, authorsList=欧阳俊芳, 张永杰, 陈西敬, authorCompany=null, correspAuthors=陈西敬, authorNote=
欧阳俊芳(1998—),男,硕士,从事新型制剂技术与成药性评价研究。
, correspAuthorsNote=
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=xln8Y3SWPRK6QLB76d+QMw==, magXml=SLgpNERozTe5zK+6DN/BGg==, pdfUrl=null, pdf=oMU5K0thofkrZ1CpuBzEYg==, pdfFileSize=2675242, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=URn6LaUoPxouWaRFGoibmQ==, mapNumber=null, fund=null)}, authors=[Author(id=1327672348670537740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672348737646606, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672348670537740, language=EN, stringName=Junfang OUYANG, firstName=Junfang, middleName=null, lastName=OUYANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672348796366863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672348670537740, language=CN, stringName=欧阳俊芳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学基础医学与临床药学学院,江苏 南京 211198, bio={"content":"
欧阳俊芳(1998—),男,硕士,从事新型制剂技术与成药性评价研究。
"}, bioImg=null, bioContent=
欧阳俊芳(1998—),男,硕士,从事新型制剂技术与成药性评价研究。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672348595040264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, xref=null, ext=[AuthorCompanyExt(id=1327672348603428873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1327672348607623178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学基础医学与临床药学学院,江苏 南京 211198)])]), Author(id=1327672348850892817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672348926390291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672348850892817, language=EN, stringName=Yongjie ZHANG, firstName=Yongjie, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672348989304852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672348850892817, language=CN, stringName=张永杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国药科大学基础医学与临床药学学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672348595040264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, xref=null, ext=[AuthorCompanyExt(id=1327672348603428873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1327672348607623178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学基础医学与临床药学学院,江苏 南京 211198)])]), Author(id=1327672349068996630, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=83271286@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672349148688408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672349068996630, language=EN, stringName=Xijing CHEN, firstName=Xijing, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672349228380185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, authorId=1327672349068996630, language=CN, stringName=陈西敬, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=中国药科大学基础医学与临床药学学院,江苏 南京 211198, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672348595040264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, xref=null, ext=[AuthorCompanyExt(id=1327672348603428873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1327672348607623178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学基础医学与临床药学学院,江苏 南京 211198)])])], keywords=[Keyword(id=1327672349316460570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=1, keyword=lipid nanocarrier), Keyword(id=1327672349379375131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=2, keyword=protein), Keyword(id=1327672349450678300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=3, keyword=peptide), Keyword(id=1327672349530370077, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=4, keyword=oral delivery), Keyword(id=1327672349584896030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=5, keyword=absorbing barrier), Keyword(id=1327672349677170719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=EN, orderNo=6, keyword=bioavailability), Keyword(id=1327672351329726496, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=1, keyword=脂质纳米载体), Keyword(id=1327672351413612577, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=2, keyword=蛋白), Keyword(id=1327672351514275874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=3, keyword=多肽), Keyword(id=1327672351581384739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=4, keyword=口服给药), Keyword(id=1327672351648493604, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=5, keyword=吸收屏障), Keyword(id=1327672351765934117, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, language=CN, orderNo=6, keyword=生物利用度)], refs=[Reference(id=1327672351979843623, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN G, KANG W, LI W,
et al.Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies [J].
Theranostics, 2022,
12(3): 1419-1439., articleTitle=null, refAbstract=null), Reference(id=1327672352185364520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=BUCHEIT J D, PAMULAPATI L G, CARTER N,
et al.Oral semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist [J].
Diabetes Technol Ther, 2020,
22(1):10-18., articleTitle=null, refAbstract=null), Reference(id=1327672352244084777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU Q, CHEN Z, PAUL P K,
et al.Oral delivery of proteins and peptides: challenges, status quo and future perspectives [J].
Acta Pharm Sin B, 2021,
11(8): 2416-2448., articleTitle=null, refAbstract=null), Reference(id=1327672352302805034, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ZOU J J, WEI G, XIONG C,
et al.Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles [J].
Sci Adv, 2022,
8(8): eabm4677., articleTitle=null, refAbstract=null), Reference(id=1327672352361525291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=MATOUGUI N, BOGE L, GROO A C,
et al.Lipid-based nanoformulations for peptide delivery [J].
Int J Pharm,2016,
502(1/2): 80-97., articleTitle=null, refAbstract=null), Reference(id=1327672352416051244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MÜLLER R H, MÄDER K, GOHLA S.Solid lipid nanoparticles(SLN) for controlled drug delivery – a review of the state of the art [J].
Eur J Pharm Biopharm, 2000,
50(1): 161-177., articleTitle=null, refAbstract=null), Reference(id=1327672352487354413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=PARK K, KWON I C, PARK K.Oral protein delivery: current status and future prospect [J].
React Funct Polym,2011,
71(3): 280-287., articleTitle=null, refAbstract=null), Reference(id=1327672352554463278, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LUNDQUIST P, ARTURSSON P.Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues [J].
Adv Drug Deliv Rev, 2016,
106(Part B): 256-276., articleTitle=null, refAbstract=null), Reference(id=1327672352634155055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=TONG T, WANG L, YOU X,
et al.Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability [J].
Biomater Sci, 2020,
8(21): 5804-5823., articleTitle=null, refAbstract=null), Reference(id=1327672352697069616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=SILVA A C, SANTOS D, FERREIRA D,
et al.Lipid-based nanocarriers as an alternative for oral delivery of poorly water-soluble drugs: peroral and mucosal routes [J].
Curr Med Chem, 2012,
19(26): 4495-4510., articleTitle=null, refAbstract=null), Reference(id=1327672352768372785, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=YUN Y, CHO YW, PARK K.Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery [J].
Adv Drug Deliv Rev, 2013,
65(6):822-832., articleTitle=null, refAbstract=null), Reference(id=1327672352827093042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=IBRAHEEM D, ELAISSARI A, FESSI H.Administration strategies for proteins and peptides [J].
Int J Pharm, 2014,
477(1/2): 578-589., articleTitle=null, refAbstract=null), Reference(id=1327672352894201907, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SARMENTO B, MAZZAGLIA D, BONFERONI M C,
et al.Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system [J].
Carbohyd Polym, 2011,
84(3): 919-925., articleTitle=null, refAbstract=null), Reference(id=1327672352973893684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SHALABY T I, EL-REFAIE W M.Bioadhesive chitosan-coated cationic nanoliposomes with improved insulin encapsulation and prolonged oral hypoglycemic effect in diabetic mice [J].
J Pharm Sci, 2018,
107(8): 2136-2143., articleTitle=null, refAbstract=null), Reference(id=1327672353045196853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HADDADZADEGAN S, DORKOOSH F, BERNKOP-SCHNÜRCH A.Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers[J].
Adv Drug Deliv Rev, 2022,
182: 114097., articleTitle=null, refAbstract=null), Reference(id=1327672353099722806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN Y, GAO Z, CHEN L,
et al.Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins [J].
Acta Pharm Sin B, 2019,
9(5): 902-922., articleTitle=null, refAbstract=null), Reference(id=1327672353154248759, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=POWELL J, PISZCZATOSKI C, TAYLOR J R.Oral semaglutide: the first-available noninjectable glucagon-like peptide 1 receptor agonist [J].
Clin Ther, 2020,
42(10):2100-2116., articleTitle=null, refAbstract=null), Reference(id=1327672353221357624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WU L, ZHANG G, LU Q,
et al.Evaluation of salmon calcitonin(sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats [J].
Drug Dev Ind Pharm, 2010,
36(3): 362-370., articleTitle=null, refAbstract=null), Reference(id=1327672353288466489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOUHAN R, GOSWAMI S, BAJPAI A K.Chapter 15 - Recent advancements in oral delivery of insulin: from challenges to solutions [M]// ANDRONESCU E, GRUMEZESCU A M.Nanostructures for oral medicine.A volume in micro and nano technologies.[S.l.]: Elsevier,2017: 435-465., articleTitle=null, refAbstract=null), Reference(id=1327672353372352570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU X, WU J, SHAN W,
et al.Sub-50 nm nanoparticles with biomimetic surfaces to sequentially overcome the mucosal diffusion barrier and the epithelial absorption barrier[J].
Adv Funct Mater, 2016,
26(16): 2728-2738., articleTitle=null, refAbstract=null), Reference(id=1327672353435267131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAN W, ZHU X, LIU M,
et al.Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin [J].
ACS Nano, 2015,
9(3): 2345-2356., articleTitle=null, refAbstract=null), Reference(id=1327672353514958908, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=ZUPANČIČ O, BERNKOP-SCHNÜRCH A.Lipophilic peptide character - what oral barriers fear the most [J].
J Control Release, 2017,
255: 242-257., articleTitle=null, refAbstract=null), Reference(id=1327672353582067773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=VLIEGHE P, LISOWSKI V, MARTINEZ J,
et al.Synthetic therapeutic peptides: science and market [J].
Drug Discov Today, 2010,
15(1/2): 40-56., articleTitle=null, refAbstract=null), Reference(id=1327672353644982334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=NAZIR I, SHAHZADI I, JALIL A,
et al.Hydrophobic H-bond pairing: a novel approach to improve membrane permeability [J].
Int J Pharm, 2020,
573: 118863., articleTitle=null, refAbstract=null), Reference(id=1327672353716285503, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=RISTROPH K D, PRUD'HOMME R K.Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers [J].
Nanoscale Adv, 2019,
1(11):4207-4237., articleTitle=null, refAbstract=null), Reference(id=1327672353787588672, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MUNTONI E, MARINI E, AHMADI N,
et al.Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary
ex vivo and
in vivo studies [J].
Acta Diabetol, 2019,
56(12): 1283-1292., articleTitle=null, refAbstract=null), Reference(id=1327672353846308929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIESSER J, HETÉNYI G, MOSER M,
et al.Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems [J].
Int J Pharm, 2017,
520(1/2):267-274., articleTitle=null, refAbstract=null), Reference(id=1327672353909223490, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=SMART A L, GAISFORD S, BASIT A W.Oral peptide and protein delivery: intestinal obstacles and commercial prospects [J].
Expert Opin Drug Deliv, 2014,
11(8): 1323-1335., articleTitle=null, refAbstract=null), Reference(id=1327672353967943748, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=ARNOLD Y E, IMANIDIS G, KUENTZ M.
In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life [J].
Drug Dev Ind Pharm, 2012,
38(10): 1262-1269., articleTitle=null, refAbstract=null), Reference(id=1327672354026664006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LEONAVICIUTE G, ZUPANČIČ O, PRÜFERT F,
et al.Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases[J].
Int J Pharm, 2016,
508(1/2): 102-108., articleTitle=null, refAbstract=null), Reference(id=1327672354097967175, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAHZADI I, FÜRST A, KNOLL P,
et al.Nanostructured lipid carriers(NLCs) for oral peptide drug delivery: about the impact of surface decoration [J].
Pharmaceutics, 2021,
13(8): 1312., articleTitle=null, refAbstract=null), Reference(id=1327672355775688776, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG T, LUO Y.Biological fate of ingested lipid-based nanoparticles: current understanding and future directions[J].
Nanoscale, 2019,
11(23): 11048-11063., articleTitle=null, refAbstract=null), Reference(id=1327672355872157769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=YUAN H, CHEN C Y, CHAI G H,
et al.Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles [J].
Mol Pharm, 2013,
10(5):1865-1873., articleTitle=null, refAbstract=null), Reference(id=1327672355939266634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=DAMGÉ C, REIS C P, MAINCENT P.Nanoparticle strategies for the oral delivery of insulin [J].
Expert Opin Drug Deliv, 2008,
5(1): 45-68., articleTitle=null, refAbstract=null), Reference(id=1327672356018958411, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ENSIGN L M, CONE R, HANES J.Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers[J].
Adv Drug Deliv Rev, 2012,
64(6): 557-570., articleTitle=null, refAbstract=null), Reference(id=1327672356102844492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=YAMANAKA Y J, LEONG K W.Engineering strategies to enhance nanoparticle-mediated oral delivery [J].
J Biomater Sci Polym Ed, 2008,
19(12): 1549-1570., articleTitle=null, refAbstract=null), Reference(id=1327672356195119181, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO S J, XU S, WANG H M,
et al.Nanoparticles: oral delivery for protein and peptide drugs [J].
AAPS PharmSciTech, 2019,
20(5): 190., articleTitle=null, refAbstract=null), Reference(id=1327672356274810958, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=ALI KHAN A, MUDASSIR J, MOHTAR N,
et al.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations [J].
Int J Nanomedicine, 2013,
8: 2733-2744., articleTitle=null, refAbstract=null), Reference(id=1327672356346114127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=BATTAGLIA L, GALLARATE M.Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery [J].
Expert Opin Drug Deliv, 2012,
9(5):497-508., articleTitle=null, refAbstract=null), Reference(id=1327672356425805904, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=WRIGHT L, BARNES T J, PRESTIDGE C A.Oral delivery of protein-based therapeutics: gastroprotective strategies, physiological barriers and
in vitro permeability prediction[J].
Int J Pharm, 2020,
585: 119488., articleTitle=null, refAbstract=null), Reference(id=1327672356572606545, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=RAJPUT A, PINGALE P, TELANGE D,
et al.Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers [J].
J Drug Deliv Sci Technol, 2021,
66: 102934., articleTitle=null, refAbstract=null), Reference(id=1327672356681658450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=DAS S, CHAUDHURY A.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery [J].
AAPS PharmSciTech, 2011,
12(1): 62-76., articleTitle=null, refAbstract=null), Reference(id=1327672356752961619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=MEANEY C M, O'DRISCOLL C M.A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt: fatty acid micellar systems using the CaCo-2 cell culture model [J].
Int J Pharm, 2000,
207(1/2): 21-30., articleTitle=null, refAbstract=null), Reference(id=1327672356836847700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Z, GAO F, JIANG S,
et al.Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats [J].
Int J Pharm,2013,
452(1/2): 374-381., articleTitle=null, refAbstract=null), Reference(id=1327672356916539477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCLEMENTS D J.Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: a review [J].
Adv Colloid Interface Sci, 2018,
253: 1-22., articleTitle=null, refAbstract=null), Reference(id=1327672357017202774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=NIU Z, CONEJOS-SÁNCHEZ I, GRIFFIN B T,
et al.Lipid-based nanocarriers for oral peptide delivery [J].
Adv Drug Deliv Rev, 2016,
106(Pt B): 337-354., articleTitle=null, refAbstract=null), Reference(id=1327672357084311639, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=TALEGAONKAR S, BHATTACHARYYA A.Potential of lipid nanoparticles(SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability[J].
AAPS PharmSciTech, 2019,
20(3): 121., articleTitle=null, refAbstract=null), Reference(id=1327672357155614808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=YU Z, FAN W, WANG L,
et al.Effect of surface charges on oral absorption of intact solid lipid nanoparticles [J].
Mol Pharm, 2019,
16(12): 5013-5024., articleTitle=null, refAbstract=null), Reference(id=1327672357222723673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=SALVI V R, PAWAR P.Nanostructured lipid carriers(NLC) system: a novel drug targeting carrier [J].
J Drug Deliv Sci Technol, 2019,
51: 255-267., articleTitle=null, refAbstract=null), Reference(id=1327672357314998362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MARTINS S, SARMENTO B, FERREIRA D C,
et al.Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles [J].
Int J Nanomedicine, 2007,
2(4): 595-607., articleTitle=null, refAbstract=null), Reference(id=1327672357390495835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=MUCHOW M, MAINCENT P, MULLER R H.Lipid nanoparticles with a solid matrix(SLN, NLC, LDC) for oral drug delivery [J].
Drug Dev Ind Pharm, 2008,
34(12):1394-1405., articleTitle=null, refAbstract=null), Reference(id=1327672357478576220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=OLBRICH C, KAYSER O, MÜLLER R H.Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles(SLN)- effect of surfactants, storage time and crystallinity[J].
Int J Pharm, 2002,
237(1/2): 119-128., articleTitle=null, refAbstract=null), Reference(id=1327672357558267997, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=PALIWAL R, RAI S, VAIDYA B,
et al.Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery [J].
Nanomedicine,2009,
5: 184-191., articleTitle=null, refAbstract=null), Reference(id=1327672357633765470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG R, GAO R, LI F,
et al.The influence of lipid characteristics on the formation,
in vitro release, and
in vivo absorption of protein-loaded SLN prepared by the double emulsion process [J].
Drug Dev Ind Pharm, 2011,
37(2):139-148., articleTitle=null, refAbstract=null), Reference(id=1327672357709262943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN C, FAN T, JIN Y,
et al.Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids [J].
Nanomedicine(Lond), 2013,
8(7): 1085-1100., articleTitle=null, refAbstract=null), Reference(id=1327672357784760416, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=GARCIA-FUENTES M, PREGO C, TORRES D,
et al.A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery [J].
Eur J Pharm Sci,2005,
25(1): 133-143., articleTitle=null, refAbstract=null), Reference(id=1327672357860257889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=FONTE P, NOGUEIRA T, GEHM C,
et al.Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin [J].
Drug Deliv Transl Res, 2011,
1(4): 299-308., articleTitle=null, refAbstract=null), Reference(id=1327672357944143970, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=FONTE P, ANDRADE F, ARAÚJO F,
et al.Chitosan-coated solid lipid nanoparticles for insulin delivery [J].
Methods Enzymol, 2012,
508: 295-314., articleTitle=null, refAbstract=null), Reference(id=1327672358040612963, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=GORDILLO-GALEANO A, MORA-HUERTAS C E.Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release [J].
Eur J Pharm Biopharm, 2018,
133: 285-308., articleTitle=null, refAbstract=null), Reference(id=1327672358099333220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=SAINI A, PANWAR D, PANESAR P S,
et al.Encapsulation of functional ingredients in lipidic nanocarriers and antimicrobial applications: a review [J].
Environ Chem Lett, 2021,
19: 1107-1134., articleTitle=null, refAbstract=null), Reference(id=1327672358170636389, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=BANERJEE S, PILLAI J.Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs[J].
Expert Opin Drug Metab Toxicol, 2019,
15(6): 499-515., articleTitle=null, refAbstract=null), Reference(id=1327672358229356646, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=DAS S, NG W K, TAN R B.Are nanostructured lipid carriers(NLCs) better than solid lipid nanoparticles(SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? [J].
Eur J Pharm Sci, 2012,
47(1): 139-151., articleTitle=null, refAbstract=null), Reference(id=1327672358313242727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=DUMONT C, JANNIN V, MIOLANE C,
et al.A proof-of-concept for developing oral lipidized peptide nanostructured lipid carrier formulations [J].
J Drug Deliv Sci Technol,2019,
54:101394., articleTitle=null, refAbstract=null), Reference(id=1327672358380351592, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=MUNTONI E, ANFOSSI L, MILLA P,
et al.Glargine insulin loaded lipid nanoparticles: oral delivery of liquid and solid oral dosage forms [J].
Nutr Metab Cardiovasc Dis,2021,
31(2): 691-698., articleTitle=null, refAbstract=null), Reference(id=1327672358447460457, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=SHRESTHA N, BOUTTEFEUX O, VANVARENBERG K,
et al.The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers [J].
Nanoscale, 2018,
10(2): 603-613., articleTitle=null, refAbstract=null), Reference(id=1327672358514569322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG Y, YU Q, CHEN Z,
et al.
In vitro and
in vivo correlation for lipid-based formulations: current status and future perspectives [J].
Acta Pharm Sin B, 2021,
11(8):2469-2487., articleTitle=null, refAbstract=null)], funds=[Fund(id=1327672351858208806, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, awardId=BK20190557, language=CN, fundingSource=江苏省自然科学基金项目(BK20190557), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1327672348595040264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, xref=null, ext=[AuthorCompanyExt(id=1327672348603428873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198), AuthorCompanyExt(id=1327672348607623178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672348007837701, companyId=1327672348595040264, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国药科大学基础医学与临床药学学院,江苏 南京 211198)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.09.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.09.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.09.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.09.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1662739200000, fullTextJson=null, articleText=null, reference=null)